(Q84127900)
Statements
Phase II study of tofacitinib (CP-690,550) combined with methotrexate in patients with rheumatoid arthritis and an inadequate response to methotrexate (English)
Yoshiya Tanaka
Makoto Suzuki
Hiroyuki Nakamura
Shigeyuki Toyoizumi
Samuel H Zwillich
Tofacitinib Study Investigators